HAMILTON THORNE LTD. Hamilton Thorne Ltd. Stock Deutsche Boerse AG
Equities
0ZM
CA4078911001
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.92 EUR | -1.08% |
|
-.--% | -3.66% |
| 05-14 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
| 05-14 | Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024 |
| Sales 2024 * | 79.33M 73.15M 108M | Sales 2025 * | 87.04M 80.26M 119M | Capitalization | 158M 145M 215M |
|---|---|---|---|---|---|
| Net income 2024 * | 1M 922K 1.36M | Net income 2025 * | 6M 5.53M 8.18M | EV / Sales 2024 * | 2.08 x |
| Net Debt 2024 * | 7.4M 6.82M 10.08M | Net cash position 2025 * | 3.1M 2.86M 4.22M | EV / Sales 2025 * | 1.78 x |
| P/E ratio 2024 * |
103
x | P/E ratio 2025 * |
25.7
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Hamilton Thorne Ltd.
More press releases
| 1 day | -1.08% | ||
| 1 month | +0.55% | ||
| 3 months | +8.88% | ||
| 6 months | +10.84% | ||
| Current year | -3.66% |
1 week
0.92
0.94
1 month
0.900.94
Current year
0.841.02
1 year
0.741.07
3 years
0.741.51
5 years
0.591.51
10 years
0.441.51
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01-14 | |
David Wolf
CHM | Chairman | - | 11-08-31 |
| Director of Finance/CFO | - | 22-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Thorne
BRD | Director/Board Member | - | 09-10-27 |
| Chief Executive Officer | - | 01-14 | |
Kari Firestone
BRD | Director/Board Member | 68 | 22-01-17 |
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.92 | -1.08% |
| 24-05-30 | 0.93 | -0.53% |
| 24-05-29 | 0.935 | +1.63% |
| 24-05-28 | 0.92 | -.--% |
| 24-05-27 | 0.92 | -.--% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 02:14 am
More quotes
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Calendar
2024-06-11
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.026
USD
Average target price
1.666
USD
Spread / Average Target
+62.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B |
- Stock Market
- Equities
- HTL Stock
- 0ZM Stock
